These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 108704)

  • 21. Antagonism of 5-hydroxytryptamine receptors by quipazine.
    Lansdown MJ; Nash HL; Preston PR; Wallis DI; Williams RG
    Br J Pharmacol; 1980 Mar; 68(3):525-32. PubMed ID: 7052342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Action of serotoninmimetics in the behavioral despair test in rats.
    Górka Z; Wojtasik E; Kwiatek H; Maj J
    Commun Psychopharmacol; 1979; 3(3):133-6. PubMed ID: 315302
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative anorexigenic activity and other pharmacological properties of quipazine and its N-acyl derivatives].
    Trubitsyna TK; Asnina VV; Mashkovskiĭ MD
    Farmakol Toksikol; 1986; 49(1):44-9. PubMed ID: 3948987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of quipazine on behavior under a multiple schedule of reinforcement.
    Poling A; Appel JB
    Pharmacol Biochem Behav; 1978 Apr; 8(4):491-2. PubMed ID: 674254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a "serotonergic syndrome" in neonatal rat pups?
    Ristine LA; Spear LP
    Pharmacol Biochem Behav; 1985 Feb; 22(2):265-9. PubMed ID: 2858868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropharmacological reassessment of the discriminative stimulus properties of d-lysergic acid diethylamide (LSD).
    Cunningham KA; Appel JB
    Psychopharmacology (Berl); 1987; 91(1):67-73. PubMed ID: 3103161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of 5-hydroxytryptamine (5-HT) receptors by quipazine [proceedings].
    Lansdown MR; Nash HL; Preston PR; Wallis DI
    Br J Pharmacol; 1979 May; 66(1):80P-81P. PubMed ID: 454965
    [No Abstract]   [Full Text] [Related]  

  • 28. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Environmental influences upon drug-induced suppression of operant behavior.
    Sparber SB; Tilson HA
    J Pharmacol Exp Ther; 1971 Oct; 179(1):1-9. PubMed ID: 5096565
    [No Abstract]   [Full Text] [Related]  

  • 30. Modification of apomorphine hypothermia by drugs affecting brain 5-hydroxytryptamine function.
    Menon MK; Vivonia CA
    Eur J Pharmacol; 1981 Dec; 76(2-3):223-7. PubMed ID: 7333357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Excellence of quipazine in the characterization of serotoninergic receptors and mechanisms].
    Hong E
    Gac Med Mex; 1982 Apr; 118(4):158-64. PubMed ID: 7117731
    [No Abstract]   [Full Text] [Related]  

  • 32. The quipazine- and TFMPP-increased conditioned avoidance response in rats: role of 5HT1C/5-HT2 receptors.
    Alhaider AA; Ageel AM; Ginawi OT
    Neuropharmacology; 1993 Dec; 32(12):1427-32. PubMed ID: 8152532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
    Eison AS; Eison MS; Yocca FD; Gianutsos G
    Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuronal 5-hydroxytryptamine receptors outside the central nervous system.
    Wallis D
    Life Sci; 1981 Dec; 29(23):2345-55. PubMed ID: 7033702
    [No Abstract]   [Full Text] [Related]  

  • 35. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan.
    Yamamoto T; Walker EA; Woods JH
    J Pharmacol Exp Ther; 1991 Sep; 258(3):999-1007. PubMed ID: 1890629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quipazine induced wet dog shake behaviour in rats: mechanism of action.
    Hiremagalur ; Keshavan JH; Dandiya PC; Gurbani NK
    Pharmacol Res Commun; 1980 Sep; 12(8):757-68. PubMed ID: 6160597
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of quipazine, a serotonin receptor agonist, on serum corticosterone concentration in rats.
    Fuller RW; Snoddy HD; Clemens JA
    Endocr Res Commun; 1978; 5(2):161-71. PubMed ID: 309816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-Hydroxytryptamine-like properties of m-chlorophenylpiperazine: comparison with quipazine.
    Rokosz-Pelc A; Antkiewicz-Michaluk L; Vetulani J
    J Pharm Pharmacol; 1980 Mar; 32(3):220-2. PubMed ID: 6103943
    [No Abstract]   [Full Text] [Related]  

  • 39. Yohimbine-induced stimulus control in the rat.
    Winter JC
    Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):86-92. PubMed ID: 736694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity to psychoactive drugs and the serotonergic neuronal system.
    Appel JB; Joseph JA; Utsey E; Hernandey LL
    Commun Psychopharmacol; 1977; 1(6):541-51. PubMed ID: 147154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.